Adli Toksikoloji

Negrusz A, Cooper G. Clarke’s Analytical Forensic Toxicology. 2nd ed. Pharmaceutical Press; 2013.

Selda M, Türkmen Z. Adli Toksikolojinin Tanımı ve Tarihsel Gelişimi. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. q. Ankara; 2018. p. 3–12.

Dağlıoğlu N, Gülmen MK, Özşeker PE. Postmortem Redistribution of Drugs Toxicological Sampling Data Assessment and Interpretation. Bull Leg Med. 2015;20(2):123–123.

Dağlıoğlu N, Özşeker PE. An Alternative Specimen in Toxicological Analysis: Nail. Bull Leg Med. 2017;22(3):na-na.

Rodda LN, Volk JA, Moffat E, Williams CM, Lynch KL, Wu AHB. Evaluation of intraosseous fluid as an alternative biological specimen in postmortem toxicology. J Anal Toxicol. 2018;62(6):1559–74.

Sadowska A, Spodnik JH, Wójcik S. Variations in popliteal fossa venous anatomy: implications for diagnosis of deep-vein thrombosis. Folia Morphol (Warsz). 2013;

Lemaire E, Schmidt C, Denooz R, Charlier C, Boxho P. Popliteal Vein Blood Sampling and the Postmortem Redistribution of Diazepam, Methadone, and Morphine. J Forensic Sci. 2016;61(4):1017–28.

Lemaire E, Schmidt C, Dubois N, Denooz R, Charlier C, Boxho P. Site-, Technique-, and Time-Related Aspects of the Postmortem Redistribution of Diazepam, Methadone, Morphine, and their Metabolites: Interest of Popliteal Vein Blood Sampling. J Forensic Sci. 2017;

Robertson MD, Drummer OH. Stability of nitrobenzodiazepines in postmortem blood. J Forensic Sci. 1998.

Drummer OH, Gerostamoulos J. Postmortem drug analysis: Analytical and toxicological aspects. Ther Drug Monit. 2002;

Al-Hadidi KA, Oliver JS. Stability of temazepam in blood. Sci Justice. 1995;

Levine B, Blanke R V, Valentour JC. Postmortem stability of benzodiazepines in blood and tissues. J Forensic Sci. 1983;

Goeringer KE, McIntyre IM, Drummer OH. Postmortem tissue concentrations of venlafaxine. Forensic Sci Int. 2001;121(1–2):70–5.

Wyman JF, Dean DE, Yinger R, Simmons A, Brobst D, Bissell M, et al. The temporal fate of drugs in decomposing porcine tissue. J Forensic Sci. 2011;56(3):694–9.

Butzbach DM, Stockham PC, Kobus HJ, Sims DN, Byard RW, Lokan RJ, et al. Stability of Serotonin-Selective Antidepressants in Sterile and Decomposing Liver Tissue,. J Forensic Sci. 2013;58(SUPPL. 1):117–25.

Avrupa Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkezi.

Özşeker PE. İnhalasyon yoluyla kannabimimetik etkiler gösteren bitkisel ürüne maruz kalan ratların biyolojik örneklerinde sentetik kannabinoid tespiti. Adana; 2017.

Labay LM, Caruso JL, Gilson TP, Phipps RJ, Knight LD, Lemos NP, et al. Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci Int. 2016;

Emniyet Genel Müdürlüğü Alkollü araç Kullanma [Internet]. [cited 2018 Aug 28]. Available from: http://www.trafik.gov.tr/Sayfalar/AlkolluAracKul.aspx

Kintz P. Forensic Applications of Hair Analysis. In: Jurado C, editor. Hair Analysis in Clinical and Forensic Toxicology. London: Academic Press; 2015. p. 241–73.

Cooper GAA, Kronstrand R, Kintz P. Society of Hair Testing guidelines for drug testing in hair. Forensic Sci Int. 2012;

Kintz P. Consensus of the Society of Hair Testing on hair testing for chronic excessive alcohol consumption 2011. Forensic Science International. 2012;

Jurado C, Soriano T, Giménez MP, Menéndez M. Diagnosis of chronic alcohol consumption: Hair analysis for ethyl-glucuronide. In: Forensic Science International. 2004.

Schmitt G, Aderjan R, Keller T, Wu M. Ethyl glucuronide: An unusual ethanol metabolite in humans. synthesis, analytical data, and determination in serum and urine. J Anal Toxicol. 1995;

Dasgupta A. Direct Alcohol Biomarkers Ethyl Glucuronide, Ethyl Sulfate, Fatty Acid Ethyl Esters, and Phosphatidylethanol. In: Alcohol and Its Biomarkers. 2015. p. 181–220.

Morini L, Politi L, Polettini A. Ethyl glucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction. 2009;

Agius R, Nadulski T, Kahl HG, Dufaux B. Ethyl glucuronide in hair - A highly effective test for the monitoring of alcohol consumption. Forensic Sci Int. 2012;

Agius R. ICADTS. 2015.

Kummer N, Wille SMR, Poll A, Lambert WEE, Samyn N, Stove CP. Quantification of EtG in hair, EtG and EtS in urine and PEth species in capillary dried blood spots to assess the alcohol consumption in driver’s licence regranting cases. Drug Alcohol Depend. 2016;

Kronstrand R, Brinkhagen L, Nyström FH. Ethyl glucuronide in human hair after daily consumption of 16 or 32g of ethanol for 3 months. Forensic Sci Int. 2012;

Liniger B, Nguyen A, Friedrich-Koch A, Yegles M. Abstinence monitoring of suspected drinking drivers: Ethyl glucuronide in hair versus CDT. Traffic Inj Prev. 2010;

Albermann ME, Musshoff F, Madea B. A fully validated high-performance liquid chromatography-tandem mass spectrometry method for the determination of ethyl glucuronide in hair for the proof of strict alcohol abstinence. In: Analytical and Bioanalytical Chemistry. 2010.

Musshoff F, Albermann E, Madea B. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods-misleading results? Int J Legal Med. 2010;

Høiseth G, Karinen R, Christophersen A, Mørland J. Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion. Int J Legal Med. 2010;

Bates MN, Blakely TA. Role of cannabis in motor vehicle crashes. Epidemiol Rev. 1999;21(2):222–32.

Schulze H, Margaritis D, Touliou A, Auerbach K. Driving under the influence of drugs, alcohol and medicines: the “DRUID” project. Road Saf four Cont 15th Int Conf Abu Dhabi, United Arab Emirates, 28-30 March 2010 Pap. 2010;

Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit. 2006;28(2):155–63.

Gülmen MK, Daglioglu N, Serin A, Battal D. Clinical legal medicine and toxicology in sexual assaults. P5 Medicine and Justice: Innovation, Unitariness and Evidence. 2018.

LeBeau M, Andollo W, Hearn WL, Baselt R, Cone E, Finkle B, et al. Recommendations for toxicological investigations of drug-facilitated sexual assaults. J Forensic Sci. 1999;

Efeoglu P, Dağlıoğlu N, Hilal A, Korkut Gulmen M. Cinsel Saldırılarda Kullanılan İlaçlar : Özellikleri ve Toksikolojik İncelemeleri. Arch Med Rev J. 2013;22(3):418–25.

Section L and S. Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts. 2011;45.

Kantarcı NM. Drug Facilitated Sexual Assault and That the Problems in Turkey. J Clin Anal Med. 2112;3(3):482–7.

T.C. Cezaevleri ve Tevkifevleri Genel Müdürlüğü [Internet]. [cited 2017 Oct 15]. Available from: http://www.cte.adalet.gov.tr/

Piquero NL. A recidivism analysis of Maryland’s community probation program. J Crim Justice. 2003;31(4):295–307.

Akgür SA. Adli Amaçlı Madde Testi: Denetimli Serbestlik Uygulaması ve Madde Testleri. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. 1st ed. Ankara: Akademisyen Kitabevi; 2018. p. 45–58.

The Substance Abuse and Mental Health Services Administration [Internet]. [cited 2017 Oct 15]. Available from: https://www.samhsa.gov/

Federal Trade Commission. Federal Trade Commission Annual Report [Internet]. 2010. Available from: https://www.ftc.gov/sites/default/files/documents/reports_annual/annual-report-2010/2010chairmansreport_0.pdf

Tsarouhas K, Kioukia-Fougia N, Papalexis P, Tsatsakis A, Kouretas D, Bacopoulou F, et al. Use of nutritional supplements contaminated with banned doping substances by recreational adolescent athletes in Athens, Greece. Food Chem Toxicol [Internet]. Elsevier; 2018;115(April):447–50. Available from: https://doi.org/10.1016/j.fct.2018.03.043

Penders J, Verstraete A. Laboratory guidelines and standards in clinical and forensic toxicology. Accredit Qual Assur. 2006;11(6):284–90.

Lillsunde P, Mukala K, Partinen R, Lamberg M. Role of occupational health services in workplace drug testing. Forensic Sci Int. 2008;174(2–3):103–6.

Verstraete A. Epidemiology of drug use in the working population. In: Verstraete A, editor. Workplace Drug Testing. Pharmaceutical Press; 2011. p. 1–4.

Phifer R. A sensible approach to workplace drug testing for cannabis. J Chem Heal Saf [Internet]. ACS Division of Chemical Health and Safety; 2017;24(2):34–8. Available from: http://dx.doi.org/10.1016/j.jchas.2016.06.004

EWDTS. European Guidelines for Workplace Drug Testing in Urine [Internet]. 2015. Available from: http://www.ewdts.org/data/uploads/documents/ewdts-urine-guideline-2015-11-01-v2.0.pdf

Bush DM. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations. Forensic Sci Int. 2008;174(2–3):111–9.

Kintz P. Alternative matrices to urine. In: Verstraete AG, editor. Workplace Drug Testing. 1st ed. Pharmaceutical Press; 2011. p. 187–212.

Department of Health and Human Services. Medical Review Officer Guidance Manual for Federal Workplace Drug Testing Programs [Internet]. 2017. Available from: https://www.samhsa.gov/sites/default/files/workplace/mro-guidance-manual-oct2017_2.pdf

Erdem A, Akgür SA, Ertaş H, Ertaş N. Kötüye Kullanılan Maddelerin Analizi. In: Akgür SA, Coşkunol H, editors. Bağımlılık Yapıcı Maddeler ve Toksikolojisi. 1st ed. İzmir: Ege Üniversitesi Basımevi; 2014.

Gürler M. Biyolojik Materyaller ve Örnek Seçimi-Antemortem Biyolojik Materyaller. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. 1st ed. Ankara: Akademisyen Kitapevi; 2018. p. 185–200.

Jaffee WB, Trucco E, Levy S, Weiss RD. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat. 2007;33(1):33–42.

Kraemer T, Paul LD. Bioanalytical procedures for determination of drugs of abuse in blood. Anal Bioanal Chem. 2007;388(7):1415–35.

Zakaria R, Allen KJ, Koplin JJ, Roche P, Greaves RF. Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process. J Int Fed Clin Chem Lab Med [Internet]. 2016;27(4):288–317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28149263%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5282914

Demirev PA. Dried blood spots: Analysis and applications. Anal Chem. 2013;85(2):779–89.

Gallardo E, Queiroz J. The role of alternative specimens in toxicological analysis. Biomed Chromatogr. 2008;(22):795–821.

Imbert L, Dulaurent S, Mercerolle M, Morichon J, Lachâtre G, Gaulier JM. Development and validation of a single LC-MS/MS assay following SPE for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites. Forensic Sci Int. 2014;234:132–8.

Kidwell DA, Holland JC, Athanaselis S. Testing for drugs of abuse in saliva and sweat. J Chromatogr B Biomed Appl. 1998;713(1):111–35.

De Giovanni N, Fucci N. The Current Status of Sweat Testing For Drugs of Abuse: A Review. Curr Med Chem [Internet]. 2013;20(4):545–61. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=0929-8673&volume=20&issue=4&spage=545

Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, et al. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Sci Int [Internet]. 2008;174(2–3):173–7. Available from: http://www.sciencedirect.com/science/article/pii/S0379073807001727

Cone E, Hillsgrove M, Jenkins A, Keenan R, Darwin W. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol. 1994;18(6):298–305.

Bogusz M, Maier R, Krüger K, Kohls U. Determination of common drugs of abuse in body fluids using one isolation procedure and liquid chromatography--atmospheric-pressure chemical-ionization mass spectromery. J Anal Toxicol. 1998;22(7):549–58.

Özdokur K, Ertaş H, Ertaş F. Analiz Yöntemlerine Genel Bakış. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. 1st ed. Ankara: Akademisyen Kitabevi; 2018. p. 171–185.

Ertaş H, Aydoğdu M, Döğer R, Ertaş N. Enstrümantal Analiz Yöntemleri- Doğrulama Aşamasında Kullanılan Kromatografik Yöntemler. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. ankara: Akademisyen Kitabevi; 2018. p. 235–60.

Adli Toksikoloji Derneği Rehber Komisyonu. Adli Toksikoloji Rehberi. In: Akgür SA, Dağlıoğlu N, editors. Temel Adli Toksikoloji. 1st ed. Ankara: Akademisyen Kitabevi; 2018. p. 1–21.